On the recordSeptember 16, 2015
Given the similarity between FDA's draft guidance and the World Health Organization's scheme on biologics qualifiers, it would be important to consult with a WHO in arriving at a global solution.
Source
congress.govEditor's note · Context
Senator Hatch emphasizes the need for global consultation with WHO on drug naming.
Share & report
More from Orrin Hatch
Jun 27, 2018
Right now, the IRS is at a critical juncture. The American people are already seeing a myriad of benefits thanks to tax reform, as unemployment continues to drop and wages rise.
Sep 3, 2018
He has shown that he brings a fair-minded approach to questions of criminal law and employment law.
Jun 25, 2018
I commend the President and the Secretary for their focus in this area and for releasing this comprehensive blueprint.
Jun 19, 2018
A strong, well-planned strategy on trade would bring the full economic might of the United States and our allies to bear on China's trade cheating.
Other voices in this conversation
